Arsenic compounds: revived ancient remedies in the fight against human malignancies

Current Opinion in Chemical Biology
Jian-Xiang LiuZhu Chen

Abstract

Arsenic, the 20th most abundant element in the earth crust, is one of the oldest drugs in the world. It was used in the 18th century in treating hematopoietic malignancies, discarded in 1950s in favor of chemotherapeutic agents (busulphan and others), and was revived in the 1970s due to its dramatic efficacy on acute promyelocytic leukemia (APL) driven by the t(15;17) translocation-generated PML-RARα fusion. Arsenic represents the most potent single agent for APL, and achieves a five-year overall survival of 90% in APL patients when combined with all-trans retinoic acid (ATRA) and chemotherapy (daunorubicin and cytarabine), turning this disease from highly fatal to highly curable. Arsenic triggers sumoylation/ubiquitination and proteasomal degradation of PML-RARα via directly binding to the C3HC4 zinc finger motif in the RBCC domain of the PML moiety and induction of its homodimerization/multimerization and interaction with the SUMO E2 conjugase Ubc9. Because of its multiplicity of targets and complex mechanisms of action, arsenic is widely tested in combination with other agents in a variety of malignancies. Other arsenic containing recipes including oral formulations and organic arsenicals are being developed and tested, and ...Continue Reading

References

Nov 5, 1998·The New England Journal of Medicine·S L SoignetR P Warrell
Sep 29, 1999·Cancer Chemotherapy and Pharmacology·S L SoignetR P Warrell
May 2, 2001·The Oncologist·S Waxman, K C Anderson
Jun 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emmanuel RaffouxHervé Dombret
Mar 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Zhi-Xiang ShenZhu Chen
Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Wen-Chien ChouChi V Dang
Apr 12, 2005·Molecular Interventions·Stanley Scheindlin
Feb 24, 2007·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Guang-Biao ZhouZhu Chen
Jul 13, 2007·Cancer Treatment Reviews·Pierre J Dilda, Philip J Hogg
Mar 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Lan WangZhu Chen
Jun 19, 2008·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Feng SunYu-bin Cheng
Oct 3, 2008·Antioxidants & Redox Signaling·Meghan B AzadSpencer B Gibson
Feb 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Qun-Ye ZhangZhu Chen
Feb 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jiong HuZhu Chen
May 7, 2009·Molecular Cancer Therapeutics·Shannon M MatulisLawrence H Boise
Jul 1, 2009·Investigational New Drugs·Jennifer WuAndrew X Zhu
Jul 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Apostolia Maria TsimberidouRazelle Kurzrock
Sep 29, 2009·Expert Opinion on Investigational Drugs·Koren K MannWilson H Miller
Oct 8, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rihab NasrHugues de Thé
Feb 19, 2010·Expert Opinion on Pharmacotherapy·Felicetto Ferrara
Mar 3, 2010·Toxicology and Applied Pharmacology·Daigo SumiYoshito Kumagai
Mar 1, 2006·Current Hematologic Malignancy Reports·Mikkael A Sekeres
May 18, 2010·Blood Reviews·Ashkan Emadi, Steven D Gore
Jul 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vikram MathewsMammen Chandy
Jul 27, 2010·The Journal of Biological Chemistry·Dennis J GoussetisLeonidas C Platanias
Aug 21, 2010·Autophagy·Stig Ove Bøe, Anne Simonsen
Sep 4, 2010·Critical Reviews in Toxicology·Erik J TokarMichael P Waalkes
Sep 4, 2010·Anti-cancer Agents in Medicinal Chemistry·Shinichiro Takahashi
Oct 23, 2010·Nature Reviews. Cancer·Hugues de Thé, Zhu Chen
Nov 4, 2010·Current Pharmaceutical Biotechnology·C AnnaloroG Lambertenghi Deliliers
Dec 1, 2010·Clinical Lymphoma, Myeloma & Leukemia·Martin TallmanMiguel A Sanz
Dec 2, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jian-Hua MaoSai-Juan Chen
Jan 11, 2011·Blood Reviews·Michael W Becker, Craig T Jordan

❮ Previous
Next ❯

Citations

Feb 7, 2013·Journal of the American Chemical Society·Aparna Sapra, Colin Thorpe
Dec 26, 2015·Viruses·Tanja KahleThomas Gramberg
Dec 29, 2015·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Szabina SticeYong Cai
Nov 29, 2014·Journal of Environmental Health Science & Engineering·Afshin MalekiAmir Hossein Mahvi
Dec 3, 2013·Biochimica Et Biophysica Acta·Rita MukhopadhyayBarry P Rosen
Jul 15, 2015·Bioinorganic Chemistry and Applications·Yuanyuan ZhangFan Jiang
Aug 31, 2014·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Jianming GuoYuping Tang
Jun 24, 2014·Drug Discovery Today·Muhammad HanifChristian G Hartinger
Oct 23, 2012·Progress in Biophysics and Molecular Biology·Kazuyo Maria Tasaki
Nov 8, 2014·Dalton Transactions : an International Journal of Inorganic Chemistry·Yuchuan WangHongzhe Sun
Jun 21, 2014·Nature Chemistry·Mackay B SteffensenHagan Bayley
Jan 28, 2016·Biological Trace Element Research·Hossein Amini-KhoeiAhmad Reza Dehpour
Feb 10, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Shuailong JiaZhifeng Du
May 11, 2020·Archives of Toxicology·Geir BjørklundMassimiliano Peana
Mar 20, 2020·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Daniela Cioloboc, Donald M Kurtz
May 29, 2018·Macromolecular Rapid Communications·Joji TanakaPaul Wilson
Apr 21, 2021·Journal of Ethnopharmacology·Sheng ZhangShen Ji
Mar 21, 2015·Journal of the American Chemical Society·Paul WilsonThomas P Davis
Jul 13, 2019·Inorganic Chemistry·Yuchuan WangHongzhe Sun
Sep 4, 2021·Chemical Science·Xuqiao HuHongzhe Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.